The {pharmaceutical industry is rapidly exploring novel treatment strategies for metabolic conditions, and the introduction of semaglutide 10mg injectables represents a significant advancement . Clinicians are beginning to consider the potential benefits and drawbacks associated with this higher potency formulation , especially in relation to exist